Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Express Scripts
Dow
McKinsey
Mallinckrodt
AstraZeneca
McKesson

Last Updated: February 20, 2020

DrugPatentWatch Database Preview

PANCURONIUM BROMIDE Drug Profile


Email this page to a colleague

See Plans and Pricing

« Back to Dashboard

Which patents cover Pancuronium Bromide, and what generic alternatives are available?

Pancuronium Bromide is a drug marketed by Dr Reddys, Elkins Sinn, Hospira, and Igi Labs Inc. and is included in eleven NDAs.

The generic ingredient in PANCURONIUM BROMIDE is pancuronium bromide. There are six drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the pancuronium bromide profile page.

US ANDA Litigation and Generic Entry Outlook for Pancuronium Bromide

A generic version of PANCURONIUM BROMIDE was approved as pancuronium bromide by HOSPIRA on January 19th, 1989.

  Start Trial

Summary for PANCURONIUM BROMIDE
Drug patent expirations by year for PANCURONIUM BROMIDE
Pharmacology for PANCURONIUM BROMIDE
Medical Subject Heading (MeSH) Categories for PANCURONIUM BROMIDE
Synonyms for PANCURONIUM BROMIDE
(2beta,3alpha,5alpha,16beta,17beta)-3,17-bis(acetyloxy)-2,16-bis(1-methylpiperidinium-1-yl)androstane dibromide
[(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-17-acetoxy-10,13-dimethyl-2,16-bis(1-methylpiperidin-1-ium-1-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate dibromide
[(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-17-acetyloxy-10,13-dimethyl-2,16-bis(1-methylpiperidin-1-ium-1-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate dibromide
1,1'-((2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-3,17-diacetoxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthrene-2,16-diyl)bis(1-methylpiperidin-1-ium) bromide
1,1'-([2beta,3alpha,5alpha,16beta,17beta]-3,17-Bis[acetyloxy]androstane-2,16-diyl)bis(1-methylpiperidinium) dibromide
1,1'-(3,17-Bis(acetyloxy)androstane-2,16-diyl)bis(1-methylpiperidinium) dibromide
1,1'-(3alpha,17beta-Bis(acetyloxy)-5alpha-androstane-2beta,16beta-diyl)bis(1-methylpiperidinium) dibromide
1,1'-(3alpha,17beta-Dihydroxy-5alpha-androstan-2beta,16beta-ylene)bis(1-methylpiperidinium) dibromide diacetate
1,1'-[(2beta,3alpha,5alpha,16beta,17beta)-3,17-bis(Acetyloxy)androstane-2,16-diyl]bis(1-methylpiperidinium) dibromide
1,1'-[2 beta,3alpha,5alpha,16 beta,17 beta)-3,17-bis(acetyloxy)-androstane-2,16-diyl]bis[1-methylpiperidinium] dibromide
15500-66-0
2beta,16beta-Dipiperidino-5alpha-androstane-3alpha,17beta-diol diacetate dimethobromide
2beta,16beta-Dipiperidino-5alpha-androstane-3alpha,17beta-dioldiacetatedimethobromide
3-alpha,17-beta-Diacetoxy-2-beta,16-beta-dipiperidino-5-alpha-androstane dimethobromide
3alpha,17beta-diacetoxy-2beta,16beta-bis(1-methylpiperidinium-1-yl)-5alpha-androstane dibromide
3alpha,17beta-Diacetoxy-2beta,16beta-dipiperidino-5alpha-androstane dimethobromide
5alpha-Androstan-3alpha,17beta-diol, 2beta,16beta-dipipecolinio-, dibromide, diacetate
AB0013311
AB2000602
AC1L1D1A
AN-7536
Bromure de pancuronium
Bromure de pancuronium [INN-French]
Bromuro de pancuronio
Bromuro de pancuronio [INN-Spanish]
C-54927
C35H60Br2N2O4
C35H60N2O4
CAS-15500-66-0
CCG-221034
CCG-222191
CHEBI:7908
CHEMBL1200757
CS-2535
D00492
DSSTox_CID_3415
DSSTox_GSID_23415
DSSTox_RID_77018
DTXSID9023415
EINECS 239-532-5
EU-0100887
H857
HMS1571O09
HMS2098O09
HMS3262B16
HMS3715O09
HSDB 3244
HY-B0429
LP00887
LS-116480
MFCD00079223
Mioblock
MolPort-003-938-961
NA 97
NCGC00163232-01
NCGC00261572-01
NSC 293162
ORG NA 97
ORG-NA 97
P 1918
Pancuronii bromidum
Pancuronii bromidum [INN-Latin]
Pancuronium (dibromide)
Pancuronium bromide (JP17/USAN/INN)
Pancuronium bromide [USAN:BAN:INN:JAN]
Pancuronium bromide [USAN:USP:INN:BAN:JAN]
Pancuronium bromide for system suitability, European Pharmacopoeia (EP) Reference Standard
Pancuronium bromide, European Pharmacopoeia (EP) Reference Standard
Pancuronium bromide, United States Pharmacopeia (USP) Reference Standard
Pancuronium dibromide
Pavulon
Pavulon (TN)
Piperidinium, 1,1'-((2beta,3alpha,5alpha,16beta,17beta)-3,17-bis(acetyloxy)androstane-2,16-diyl)bis(1-methyl-, dibromide
Piperidinium, 1,1'-((2beta,3alpha,5alpha,16beta,17beta)-3,17-bis(acetyloxy)androstane-2,16-diyl)bis(1-methyl)-, dibromide
Piperidinium, 1,1'-(2-beta,16-beta-(3-alpha,17-beta-dihydroxy-5-alpha-androstanylene))bis(1-methyl-, dibromide, diacetate
Piperidinium, 1,1'-(3alpha,17beta-dihydroxy-5alpha-androstan-2beta,16beta-ylene)bis(1-methyl-, dibromide, diacetate
Piperidinium, 1,1'-(3alpha,17beta-dihydroxy-5alpha-androstan-2beta,16beta-ylene)bis(1-methyl-, dibromide, diacetate (8CI)
Q-101015
s2497
SC-22780
SCHEMBL41185
SR-01000000127
SR-01000000127-3
SR-01000076059
SR-01000076059-1
Tox21_112033
Tox21_500887
U9LY9Y75X2
UNII-U9LY9Y75X2

US Patents and Regulatory Information for PANCURONIUM BROMIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Dr Reddys PANCURONIUM BROMIDE pancuronium bromide INJECTABLE;INJECTION 072759-001 Jul 31, 1990 AP RX No Yes   Start Trial   Start Trial   Start Trial
Hospira PANCURONIUM BROMIDE pancuronium bromide INJECTABLE;INJECTION 072321-001 Jan 19, 1989 DISCN No No   Start Trial   Start Trial   Start Trial
Elkins Sinn PANCURONIUM BROMIDE pancuronium bromide INJECTABLE;INJECTION 072059-001 Mar 23, 1988 DISCN No No   Start Trial   Start Trial   Start Trial
Igi Labs Inc PANCURONIUM BROMIDE pancuronium bromide INJECTABLE;INJECTION 072210-001 Mar 31, 1988 DISCN No No   Start Trial   Start Trial   Start Trial
Dr Reddys PANCURONIUM BROMIDE pancuronium bromide INJECTABLE;INJECTION 072760-001 Jul 31, 1990 RX No Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Johnson and Johnson
AstraZeneca
Medtronic
Express Scripts
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.